An#microbial studies of Marine Natural Product Mimics (MNPMs) E. Mishchenko1, E. M. Igumnova2, H-M. Blencke1,E.G.A. Fredheim3, J. U. E. Sollid4,5, T. Haug1,5, M. B. Strøm2, K. Stensvåg1,5 1) Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics (BFE), UiT The Arctic University of Norway, Breivika, N-9037 Tromsø, Norway Faculty of Health Science: 2) Department of Pharmacy, 3) Department of Clinical Medicine, 4) Department of Medical Biology 5) Centre for Research-based Innovation on marine bioactives and drug discovery (MabCent-CRI), BFE, UiT The Arctic University of Norway INTRODUCTION EFFECT ON BACTERIAL CELL MEMBRANE Medical device-associated infections caused by staphylococcal biofilms comprise a significant part of all cases of nosocomial infections. Staphylococcus aureus and Staphylococcus epidermidis are among the leading causative agents of bacteremia [1]. The intrinsic reduced antimicrobial susceptibility and rapid antibiotic resistance development is a great treatment challenge of biofilm-associated infections [2]. Compound C affects membrane integrity of B. subtilis biosensor Relative Luminecsence Units Natural products (NP) from marine organisms have a unique structure and wide spectrum of bioactivity [3]. Marine natural product mimics (MNPMs) with improved characteristics compared to the original NPs could be promising antibiofilm agents effective against dormant and persister cells within a biofilm matrix due to the specific mode of action. 120 2xMIC 1xMIC 100 0,5xMIC 80 Water Chlorhexidine 60 40 20 0 Aim: To study the antimicrobial and anti-biofilm activity of the library of MNPMs to reveal promising candidates for further development into novel therapeutics 0 50 100 Time, sec S. epidermidis biofilms were grown in chambered slides and then incubated with compound C. Treated biofilms were examined using confocal laser scanning microscope (CLSM) [6] in combination with fluorescent LIVE (SYTO 9) / DEAD (Propidium iodide) staining. Antimicrobial and anti-biofilm screening: Panel of 6 test bacterial species In vitro S. epidermidis biofilm models Follow-up studies on selected compounds: Mode of action Anti-biofilm properties / ANTIMICROBIAL ACTIVITY OF SELECTED MNPMS Minimal inhibitory concentration (MIC), µg/ml [4] S. epidermidis RP62A S. epidermidis 5179-R1 B. subtilis 168 E. coli ATCC 25922 P. aeruginosa PAO1 E 1,0 3,1 1,9 1,9 3,9 1,6 1,0 31,3 31,3 15,6 15,6 >125 62,5 15,6 7,8 7,8 7,8 3,9 6,3 3,9 3,9 Antibiotic control 0.5 (Vancomycin) 0.8 (Vancomycin) 0.6 (Erythromycin) 0.8 (Polymyxin B) Alive biomass 0.4 (Polymyxin B) Dead biomass and extracellular DNA MIC increase after serial passages through subMIC concentrations, µg/ml S. epidermidis RP62A Double B. subtilis 168 No increase A lot of dead biomass Bildetekst settes her… Significant biomass eradica#on Compound C was selected for follow-up studies Compound C, 5 x MIC Hemolytic activity (Human Red Blood Cells), EC50, µg/ml 61,4 176,0 >500 64,6 33,8 Untreated control Polysaccharide biofilm of RP62A Selected test strains Selected compounds A B C D 3,9 3,9 3,9 3,9 S. epidermidis biofilm killing and eradication by compound C Proteinateous biofilm of R1-5179 Library of > 130 MNPMs with molecular weights ≤ 500 Da Compound C effectively penetrates through S. epidermidis biofilm. Antibiotic disc Compound C rapidly kills S. epidermidis in liquid culture Biofilm 6 Compound C 5 4 3 2 1 0 control 1 2 Incubation time, hours Compound C 1xMIC 3 Compound C 5xMIC 4 Vancomycin 5xMIC S. epidermidis was treated with test compounds and aliquotes were plated for colony forming units (CFU) counting over several time points. Compound C causes membrane potential alterations in bacteria E.coli S.epidermidis 6 10 5 Red/Green ra#o Red/Green ra#o 12 3 6 Bacteria were treated with compound C and stained with green fluorophore DiOC2(3) which becomes red due to cell membrane potential. 2 4 1 2 Nonetreated Compound C Compound C control 4 MIC 2 MIC Treatment 1. Novel MNPMs with promising antimicrobial activity were identified 2. The MNPMs were shown to be bactericidal and membranolytic. 3. High in vitro efficiency against mature S. epidermidis biofilms was revealed References: 0 0 S. epidermidis biofilms were grown on membrane filters (pore size 0.2 µm). Control strain (C. glutamicum) was incubated on agar plates with the test compounds placed on top of biofilms. Zones of growth inhibition were compared to control setups without biofilms [7]. 4. Further studies are needed to reveal the molecular targets of selected MNPMs 4 8 Membrane filter / CONCLUSION EFFECT ON BACTERIAL CELL MEMBRANE DiOC2 (3) Vancomycin Log CFU/ml 200 / ANTI-BIOFILM STUDIES / STRATEGY 0 150 B. subtilis luciferaseexpressing strain was treated with compound C. Light emission caused by membrane disruption and substrate penetration into cells was measured in realtime [5]. Nonetreated Compound C Compound C control 2 MIC 1 MIC Treatment Changes in membrane potential lead to changes in red/green ratio. Fluorescence intensities of bacterial populations were measured by flow cytometry. 1. NORM/NORM-VET 2012. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø / Oslo 2013. ISSN: 1890-9965. 2. Hall-Stoodley, et al. Nat Rev Microbiol, 2004. 2(2): 95 - 108. 3. Sperstad, S. V., et al. Biotech Adv, 2011. 29(4): 519-530. 4. Haug, T., et al. Fish Shellfish Immun, 2002. 12(5): 371-385. 5. Virta, M., et al. J Antimicrob Chemoth, 1995. 36(2): p. 303-315 6. Christensen, B.B., et al. Molecular tools for study of biofilm physiology. In Methods Enzymol. Academic Press, Inc. 1999. 20-42. 7. Singh R et al. J. Antimicrob. Chemother. 2010. 65(9): 1955-1958
© Copyright 2024